Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems
- PMID: 18195568
- PMCID: PMC2247409
- DOI: 10.1097/QAD.0b013e3282f423f8
Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems
Abstract
Objective: To assess the impact of recent heavy alcohol use, heroin/cocaine use, and homelessness on short-term mortality in HIV-infected persons.
Methods: Survival in a longitudinal cohort of 595 HIV-infected persons with alcohol problems was assessed at 6-month intervals in 1996-2005. The time-varying main independent variables were heavy alcohol use (past 30 days), heroin/cocaine use (past 6 months), and homelessness (past 6 months). Date of death was determined using the Social Security Death Index. Outcomes were limited to deaths occurring within 6 months of last assessment to ensure recent assessments of the main independent variables. Cox proportional hazards models were fit to the data.
Results: Death within 6 months of their last assessment occurred in 31 subjects (5.2%). Characteristics at study entry included mean age 41 years, 25% female, 41% African-American, 24% with CD4 cell count < 200 cells/mul; 41% taking antiretroviral therapy, 30% heavy alcohol use, 57% heroin or cocaine use, and 28% homelessness. Heroin or cocaine use [hazard ratio (HR), 2.43; 95% confidence interval (CI), 1.12-5.30)] and homelessness (HR, 2.92; 95% CI, 1.32-6.44), but not heavy alcohol use (HR, 0.57; 95% CI, 0.23-1.44), were associated with increased mortality in analyses adjusted for age, injection drug use ever, CD4 cell count, and current antiretroviral therapy.
Conclusions: Recent heroin or cocaine use and homelessness are associated with increased short-term mortality in HIV-infected patients with alcohol problems. Optimal management of HIV-infected patients requires regular assessments for drug use and homelessness and improved access to drug treatment and housing.
References
-
- Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18:1835–1843. - PubMed
-
- Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. HIV Outpatient Study Investigators Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–860. - PubMed
-
- Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, et al. Multicenter AIDS Cohort Study Investigators Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280:1497–1503. - PubMed
-
- Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17–26. - PubMed
Publication types
MeSH terms
Grants and funding
- R25 DA013582/DA/NIDA NIH HHS/United States
- K24 AA015674/AA/NIAAA NIH HHS/United States
- M01 RR000533/RR/NCRR NIH HHS/United States
- T32 AI052074/AI/NIAID NIH HHS/United States
- R01 AA013216/AA/NIAAA NIH HHS/United States
- R01-AA10870/AA/NIAAA NIH HHS/United States
- R01-AA13216/AA/NIAAA NIH HHS/United States
- M01 RR01032/RR/NCRR NIH HHS/United States
- M01 RR00533/RR/NCRR NIH HHS/United States
- R01 AA010870/AA/NIAAA NIH HHS/United States
- R25-DA13582/DA/NIDA NIH HHS/United States
- T32-AI52074/AI/NIAID NIH HHS/United States
- M01 RR001032/RR/NCRR NIH HHS/United States
- R01 AA011785/AA/NIAAA NIH HHS/United States
- R01-AA11785/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
